Alessandro D. Santin, MD
Professor of Obstetrics, Gynecology, and Reproductive Sciences
Departments & Organizations
Yale Medical Group
Cancer Center, Yale: Gynecologic Oncology Program | Cancer - Uterus | Molecular Virology
Obstetrics, Gynecology & Reproductive Sciences: Gynecologic Oncology | Ovarian Cancer Program, Early Detection | Cancer Biology Group | Women's Reproductive Health Research Career Development Center
Research Interests
Therapeutic vaccine development for gynecologic malignancies; Tumor immunology; immunotherapy; tumor angiogenesis; radiation biology; experimental therapeutics in gynecologic oncology more...
Education
- M.D., University of Brescia School of Medicine, 1989
Selected Publications
- El-Sahwi K, Bellone S, Cocco E, Cargnelutti M, Casagrande F, Bellone M, Abu-Khalaf M, Buza N, Tavassoli FA, Hui P, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma. British Journal of Cancer. 102(1):134-43, 2010.
- El-Shawi K, Bellone S, Cocco E, Casagrande F, Bellone M, Abu-khalaf M, Buza N, Tavassoli FA, Hui P, Ruttinger D, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-Specific immunotherapy with human monoclonal antibody Adecatumumab (MT201). Mol Cancer Ther, 9(1): 58-66, 2010.
- Cocco E, Bellone S, El-Shawi K, Cargnelutti M, Buza N, Tavassoli FA, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Serum amyloid A: a novel biomarker for uterine serous papillary cancer. British Journal of Cancer, 101(2):335-41, 2009.
